JayTee2328Nov 01, 20 2:02 PM
After market close on Friday announced Phase 3 trial results: https://finance.yahoo.com/news/rhythm-pharmaceuticals-announces-publication-results-233000410.html
Date | Price | |
---|---|---|
Entry | 12/16/2022 | 25.99 |
Exit | 4/17/2023 | 31.04 |
After market close on Friday announced Phase 3 trial results: https://finance.yahoo.com/news/rhythm-pharmaceuticals-announces-publication-results-233000410.html
Analyst Actions: Morgan Stanley Adjusts Price Target on Rhythm Pharmaceuticals to $57 From $53, Maintains Overweight Rating
4/10/23 sold 200 at end of 2022 for a tax loss offset...sitll hold 5.36 share and may buy more At <$17